✦ LIBER ✦

Docetaxel as salvage chemotherapy in patients with advanced non-small cell lung cancer after failure of cytotoxic agents and gefitinib treatment

✍ Scribed by Yilong Wu; Jinji Yang; Yujuan Huang; Qin Zhou; Yisheng Huang; Chongrui Xu

Publisher: Springer
Year: 2008
Tongue: English
Weight: 545 KB
Volume: 7
Category: Article
ISSN: 1610-1979
DOI: 10.1007/s10330-008-0105-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib as salvage treatment after fai

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer

✍ Matthew K. Wong; Alvis I. Lo; Bing Lam; W. K. Lam; Mary S. Ip; James C. Ho 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 197 KB

Combination versus sequential single-age

Combination versus sequential single-agent chemotherapy in the treatment of patients with advanced non-small cell lung cancer

✍ Niell, Harvey B. ;Griffin, John P. ;Hunter, Robert F. ;Meredith, Charlotte A. ;S 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

We have carried out a randomized phase Ill study in 105 patients with advanced nonsmall cell lung cancer, comparing a fourdrug cisplatin-mitomycin-based combination chemotherapy regimen t o sequential single-agent therapy. The combination chemotherapy regimen consisted of mitomycin C (10 mg/m2), vin

Gemcitabine plus docetaxel as first-line

Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB

EGFR / HER2 / HER3 expression in tumour

EGFR / HER2 / HER3 expression in tumour and gefitinib treatment in Chinese patients with advanced non-small cell lung cancer

✍ Jianming Xu; Emei Gao; Yu Han; Yang Zhang; Suxia Li; Xiaoqing Liu; Zhiqiang Li; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 282 KB

Phase I study of second-line chemotherap

Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer

✍ Mikio Oka; Minoru Fukuda; Seiji Nagashima; Masaaki Fukuda; Akitoshi Kinoshita; H 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 84 KB

A triplet chemotherapy with cisplatin, d

A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study

✍ Masahiro Tabata; Toshiyuki Kozuki; Hiroshi Ueoka; Katsuyuki Kiura; Shingo Harita 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 276 KB